Form 4: MDGL Director Sells Shares for Tax Obligations

Madrigal Pharmaceuticals Director Rebecca Taub sold 2,238 shares of common stock at $490.77 each to cover tax withholding obligations from restricted stock unit vesting.

Summary

• Rebecca Taub, a Director of Madrigal Pharmaceuticals, Inc. (MDGL), reported a sale of 2,238 shares of common stock.
• The transaction occurred on January 20, 2026, at a price of $490.77 per share.
• The sale was automatic and non-discretionary, executed by the Issuer to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Rebecca Taub directly beneficially owns 453,351 shares of common stock.
• Additionally, 655,540 shares are indirectly beneficially owned through SQN LLC, where Rebecca Taub and her spouse are managing members.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary sale of shares by a director to cover tax withholding obligations, which is a neutral event for the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction filing and does not provide information relevant to broader industry trends or competitor analysis.

Related Party Transactions

• Rebecca Taub and her spouse are managing members of SQN, LLC, which indirectly beneficially owns 655,540 shares of Madrigal Pharmaceuticals common stock. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest.

Stakeholder Impact

• Shareholders: Minimal impact as the transaction is a routine, non-discretionary sale for tax purposes, not indicative of a change in management's confidence or company fundamentals.

Key Dates

Keywords

Madrigal Pharmaceuticals, MDGL, Form 4, Insider Transaction, Stock Sale, Director, Rebecca Taub, Tax Withholding, RSU Vesting